• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Travel Med Infect Dis . SARS-CoV-2 RT-PCR positivity of individuals subsequent to completing quarantine upon entry into a country during a transmis

tetano

Editor, Senior Moderator
Travel Med Infect Dis


. 2022 Feb 2;102271.
doi: 10.1016/j.tmaid.2022.102271. Online ahead of print.
SARS-CoV-2 RT-PCR positivity of individuals subsequent to completing quarantine upon entry into a country during a transmission-free period


Sirawat Srichatrapimuk[SUP] 1 [/SUP], Thanat Chookajorn[SUP] 2 [/SUP], Theerarat Kochakarn[SUP] 2 [/SUP], Suppachok Kirdlarp[SUP] 1 [/SUP], Ekawat Pasomsu[SUP] 3 [/SUP], Wasun Chantratita[SUP] 4 [/SUP], Sopon Iamsirithaworn[SUP] 5 [/SUP], Mongkol Kunakorn[SUP] 3 [/SUP], Arunee Thitithanyanont[SUP] 6 [/SUP], Somnuek Sungkanuparph[SUP] 1 [/SUP], Angsana Phuphuakrat[SUP] 7 [/SUP]



Affiliations

Abstract

Background: During the current coronavirus disease 2019 (COVID-19) pandemic, many countries require travellers to undergo a reverse transcription-polymerase chain reaction (RT-PCR) testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) before travelling across borders. However, in persons having recovered from COVID-19, RT-PCR positivity can persist for an extended period.
Materials and methods: We describe three cases who sought fit-to-fly certificates in Thailand during the period free of local transmission but were tested positive for RT-PCR for SARS-CoV-2. All had returned from a country with an active outbreak of COVID-19. Their clinical courses are described; positive nasopharyngeal swab samples were processed for viral isolation and whole-genome sequencing (WGS); and serology as well as neutralizing antibody were assessed. The contact tracing was carried out for determining evidence of indigenous transmission among close contacts of those three cases.
Results: All three cases were completely asymptomatic. Chest computerized tomography was not compatible with COVID-19 pneumonia; cell cultures failed to rescue replication-competent virus; WGS revealed fragmented viral genetic material from nasopharyngeal swab samples; and serological tests demonstrated stable levels of antibodies, together with the presence of neutralizing antibody, suggesting past infection with negligible transmission risk. Contact tracing identified no transmission in high-risk close contact individuals.
Conclusion: RT-PCR positivity for SARS-CoV-2 might detect fragmented viral genome. Issuance of a travel certificate in these circumstances is problematic. Serology tests can help to define past infection. A practical acceptable set of guidelines for issuance of a COVID-19 safety travel certification is a necessity.

Keywords: COVID-19; RT-PCR; SARS-CoV-2; Serology; Travel certificate.
 
Back
Top Bottom